Current status: 973 hESC lines, 6222 hiPSC lines, and 147 clinical studies, and 2310 certificates
Monthly statistic from Jun 1, 2024
Posted on June 1, 2024
| total lines | 7195 |
| hESC lines | 973 |
| hiPSC lines | 6222 |
| derivation countries | 47 |
| projects | 300 |
| providers | 907 |
| clinical studies | 147 |
| subclones | 2846 |
| certificates | 2310 |
| cell line certificates | 2166 |
| project certificates | 144 |